Learning Collaborative Promotes Mifepristone Education and Utilization Training in Federally Qualified Health Centers
Researchers created a learning collaborative that included implementing an intervention titled, “Excellence in Providing Access to New Directions in Mifepristone Use (ExPAND Mifepristone)” in two Chicago-area Federally Qualified Health Centers with a focus on enhancing educational and training support services for primary care doctors and staff to use mifepristone for miscarriage management and abortion provision.
Prior to program implementation, clinicians and staff had little knowledge of mifepristone. After program implementation and completion, both clinics stocked and provided mifepristone for early pregnancy loss. However, significant barriers remained for use of the drug as part of abortion care. Doctors at both program sites noted that stringent financial procedures to separate federal funds from those that support abortion procedures proved a significant challenge. Despite these obstacles, the researchers believe that the participating clinics’ expanded ability to provide mifepristone for early pregnancy loss suggests that learning collaboratives could be an effective tool in improving access to comprehensive reproductive care.
What We Know: Primary care physicians face various barriers in providing mifepristone for early pregnancy loss and/or abortion, despite mifepristone being FDA-approved and highly effective for use in abortion at 10 or fewer weeks when paired with misoprostol. Based on study interviews with primary care physicians and previous research, modifying medication protocols is not enough to change the clinical practice of prescribing mifepristone.
What This Study Adds: Study authors determined that clinics need to build skills, self-efficacy, and capacity to create practice change. Their “Excellence in Providing Access to New Directions in Mifepristone Use (ExPAND Mifepristone)” learning collaborative enhanced educational and training support services for primary care doctors to use mifepristone for miscarriage management and abortion provision. Through the intervention, clinicians and staff increased their knowledge of mifepristone and were able to stock and provide the medication for early pregnancy loss. Despite existing obstacles that hindered clinicians from prescribing the drug for abortion, the study authors believe that the learning collaborative can be an effective way to improve overall access to comprehensive reproductive care.
ExPAND Mifepristone: Medical Management of Miscarriage and Abortion in FQHCs
Lisa Wu, BS, et al
University of Chicago Pritzker School of Medicine, Chicago, Illinois
Pre-embargo article link (Link expires at 5 p.m. EDT Sept. 25, 2023)
Permanent link
The Annals of Family Medicine